Cargando…

RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery

The use of NIR-fluorescence imaging to demarcate tumour boundaries for real-time guidance of their surgical resection has a huge untapped potential. However, fluorescence imaging using molecular fluorophores, even with a targeting biomolecule attached, has a major shortcoming of signal interference...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dan, Daly, Harrison C., Grossi, Marco, Conroy, Emer, Li, Bo, Gallagher, William M., Elmes, Robert, O'Shea, Donal F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686729/
https://www.ncbi.nlm.nih.gov/pubmed/31588261
http://dx.doi.org/10.1039/c9sc02197c
_version_ 1783442622690361344
author Wu, Dan
Daly, Harrison C.
Grossi, Marco
Conroy, Emer
Li, Bo
Gallagher, William M.
Elmes, Robert
O'Shea, Donal F.
author_facet Wu, Dan
Daly, Harrison C.
Grossi, Marco
Conroy, Emer
Li, Bo
Gallagher, William M.
Elmes, Robert
O'Shea, Donal F.
author_sort Wu, Dan
collection PubMed
description The use of NIR-fluorescence imaging to demarcate tumour boundaries for real-time guidance of their surgical resection has a huge untapped potential. However, fluorescence imaging using molecular fluorophores, even with a targeting biomolecule attached, has a major shortcoming of signal interference from non-specific background fluorescence outside the region of interest. This poor selectivity necessitates prolonged time delays to allow clearance of background fluorophore and retention within the tumour prior to image acquisition. In this report, an innovative approach to overcome this issue is described in which cancer targeted off to on bio-responsive NIR-fluorophores are utilised to switch-on first within the tumour. Bio-responsive cRGD, iRGD and PEG conjugates have been synthesised using activated ester/amine or maleimide/thiol couplings to link targeting and fluorophore components. Their off to on emission responses were measured and compared with an always-on non-responsive control with each bio-responsive derivative showing large fluorescence enhancement values. Live cell imaging experiments using metastatic breast cancer cells confirmed in vitro bio-responsive capabilities. An in vivo assessment of MDA-MB 231 tumour imaging performance for bio-responsive and always-on fluorophores was conducted with monitoring of fluorescence distributions over 96 h. As anticipated, the always-on fluorophore gave an immediate, non-specific and very strong emission throughout whereas the bio-responsive derivatives initially displayed very low fluorescence. All three bio-responsive derivatives switched on within tumours at time points consistent with their conjugated targeting groups. cRGD and iRGD conjugates both had effective tumour turn-on in the first hour, though the cRGD derivative had superior specificity for tumour over the iRGD conjugate. The pegylated derivative had similar switch-on characteristics but over a much longer period, taking 9 h before a significant emission was observable from the tumour. Evidence for in vivo active tumour targeting was obtained for the best performing cRGD bio-responsive NIR-AZA derivative from competitive binding studies. Overall, this cRGD-conjugate has the potential to overcome the inherent drawback of targeted always-on fluorophores requiring prolonged clearance times and shows excellent potential for clinical translation for intraoperative use in fluorescence guided tumour resections.
format Online
Article
Text
id pubmed-6686729
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-66867292019-10-04 RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery Wu, Dan Daly, Harrison C. Grossi, Marco Conroy, Emer Li, Bo Gallagher, William M. Elmes, Robert O'Shea, Donal F. Chem Sci Chemistry The use of NIR-fluorescence imaging to demarcate tumour boundaries for real-time guidance of their surgical resection has a huge untapped potential. However, fluorescence imaging using molecular fluorophores, even with a targeting biomolecule attached, has a major shortcoming of signal interference from non-specific background fluorescence outside the region of interest. This poor selectivity necessitates prolonged time delays to allow clearance of background fluorophore and retention within the tumour prior to image acquisition. In this report, an innovative approach to overcome this issue is described in which cancer targeted off to on bio-responsive NIR-fluorophores are utilised to switch-on first within the tumour. Bio-responsive cRGD, iRGD and PEG conjugates have been synthesised using activated ester/amine or maleimide/thiol couplings to link targeting and fluorophore components. Their off to on emission responses were measured and compared with an always-on non-responsive control with each bio-responsive derivative showing large fluorescence enhancement values. Live cell imaging experiments using metastatic breast cancer cells confirmed in vitro bio-responsive capabilities. An in vivo assessment of MDA-MB 231 tumour imaging performance for bio-responsive and always-on fluorophores was conducted with monitoring of fluorescence distributions over 96 h. As anticipated, the always-on fluorophore gave an immediate, non-specific and very strong emission throughout whereas the bio-responsive derivatives initially displayed very low fluorescence. All three bio-responsive derivatives switched on within tumours at time points consistent with their conjugated targeting groups. cRGD and iRGD conjugates both had effective tumour turn-on in the first hour, though the cRGD derivative had superior specificity for tumour over the iRGD conjugate. The pegylated derivative had similar switch-on characteristics but over a much longer period, taking 9 h before a significant emission was observable from the tumour. Evidence for in vivo active tumour targeting was obtained for the best performing cRGD bio-responsive NIR-AZA derivative from competitive binding studies. Overall, this cRGD-conjugate has the potential to overcome the inherent drawback of targeted always-on fluorophores requiring prolonged clearance times and shows excellent potential for clinical translation for intraoperative use in fluorescence guided tumour resections. Royal Society of Chemistry 2019-06-21 /pmc/articles/PMC6686729/ /pubmed/31588261 http://dx.doi.org/10.1039/c9sc02197c Text en This journal is © The Royal Society of Chemistry 2019 http://creativecommons.org/licenses/by/3.0/ This article is freely available. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (CC BY 3.0)
spellingShingle Chemistry
Wu, Dan
Daly, Harrison C.
Grossi, Marco
Conroy, Emer
Li, Bo
Gallagher, William M.
Elmes, Robert
O'Shea, Donal F.
RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title_full RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title_fullStr RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title_full_unstemmed RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title_short RGD conjugated cell uptake off to on responsive NIR-AZA fluorophores: applications toward intraoperative fluorescence guided surgery
title_sort rgd conjugated cell uptake off to on responsive nir-aza fluorophores: applications toward intraoperative fluorescence guided surgery
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686729/
https://www.ncbi.nlm.nih.gov/pubmed/31588261
http://dx.doi.org/10.1039/c9sc02197c
work_keys_str_mv AT wudan rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT dalyharrisonc rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT grossimarco rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT conroyemer rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT libo rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT gallagherwilliamm rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT elmesrobert rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery
AT osheadonalf rgdconjugatedcelluptakeofftoonresponsivenirazafluorophoresapplicationstowardintraoperativefluorescenceguidedsurgery